A Breakthrough in Digestive Health
Scientists from IIT Delhi and AIIMS New Delhi have successfully developed a swallowable “smart pill” capable of collecting microbiome samples directly from the intestine. This innovation promises to significantly advance the study and diagnosis of digestive diseases. As per Economic Times, the project received funding from the Indian Council of Medical Research (ICMR) and addresses long-standing challenges in microbiome research.
Overcoming Traditional Limitations
Gut microbes influence conditions ranging from inflammatory bowel disease and infections to diabetes and neurological disorders. Despite their importance, studying these microbes has been difficult because conventional methods are either invasive, such as endoscopy, or indirect, relying on stool samples. The new smart pill provides a minimally invasive alternative that allows precise, site-specific sampling.
How the Smart Pill Works
The pill-sized microdevice, measuring just 7 mm by 2.7 mm, is encased in an enteric-coated gelatin shell. This coating protects it from stomach acid. Upon reaching the intestine, the coating dissolves in the higher pH environment, allowing intestinal fluid to enter. A specialized hydrogel then seals the inlet, preventing contamination while the pill continues its journey through the gut. In animal tests, four out of five pills safely completed intestinal transit and provided enough genetic material for detailed microbial sequencing.
Exploring the Human Microbiome
Beyond bacteria, the smart pill can detect intestinal alkaline phosphatase, a key biochemical marker of gut health. Using nanopore sequencing, researchers identified microbes down to the species level. Prof. Sarvesh Kumar Srivastava from IIT Delhi likened this exploration to sending rovers into outer space, highlighting the “hidden universe of living microbes” within the human body.
Future Clinical Applications
Dr. Samagra Agarwal from AIIMS emphasized that direct study of the small intestine could open new possibilities for early disease detection, monitoring chronic conditions, and developing targeted treatments. Although current research is limited to animal studies, scientists believe the technology provides strong proof of concept for future human applications, potentially transforming personalized medicine and gut health research.